Literature DB >> 19299654

Intriguing response to azacitidine in a patient with juvenile myelomonocytic leukemia and monosomy 7.

Ingrid Furlan, Christiane Batz, Christian Flotho, Brigitte Mohr, Michael Lübbert, Meinolf Suttorp, Charlotte M Niemeyer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19299654     DOI: 10.1182/blood-2008-12-195693

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  23 in total

Review 1.  New ways to use DNA methyltransferase inhibitors for the treatment of myelodysplastic syndrome.

Authors:  Steven D Gore
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2011

Review 2.  Treatment advances for pediatric and adult onset neoplasms with monocytosis.

Authors:  Kristen B McCullough; Alexis K Kuhn; Mrinal M Patnaik
Journal:  Curr Hematol Malig Rep       Date:  2021-03-16       Impact factor: 3.952

3.  Molecular basis of juvenile myelomonocytic leukemia.

Authors:  Andrica C H de Vries; C Michael Zwaan; Marry M van den Heuvel-Eibrink
Journal:  Haematologica       Date:  2010-02       Impact factor: 9.941

4.  Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine.

Authors:  William Blum; Ramiro Garzon; Rebecca B Klisovic; Sebastian Schwind; Alison Walker; Susan Geyer; Shujun Liu; Violaine Havelange; Heiko Becker; Larry Schaaf; Jon Mickle; Hollie Devine; Cheryl Kefauver; Steven M Devine; Kenneth K Chan; Nyla A Heerema; Clara D Bloomfield; Michael R Grever; John C Byrd; Miguel Villalona-Calero; Carlo M Croce; Guido Marcucci
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-05       Impact factor: 11.205

Review 5.  How much? How frequent? How long? A clinical guide to new therapies in myelodysplastic syndromes.

Authors:  William Blum
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2010

Review 6.  Gene mutations do not operate in a vacuum: the increasing importance of epigenetics in juvenile myelomonocytic leukemia.

Authors:  Christian Flotho
Journal:  Epigenetics       Date:  2019-03-08       Impact factor: 4.528

7.  Epigenetic silencing of AKAP12 in juvenile myelomonocytic leukemia.

Authors:  Thomas Wilhelm; Daniel B Lipka; Tania Witte; Justyna A Wierzbinska; Silvia Fluhr; Monika Helf; Oliver Mücke; Rainer Claus; Carolin Konermann; Peter Nöllke; Charlotte M Niemeyer; Christian Flotho; Christoph Plass
Journal:  Epigenetics       Date:  2016-02-18       Impact factor: 4.528

8.  Criteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemia.

Authors:  Charlotte M Niemeyer; Mignon L Loh; Annamaria Cseh; Todd Cooper; Christopher C Dvorak; Rebecca Chan; Blanca Xicoy; Ulrich Germing; Seiji Kojima; Atsushi Manabe; Michael Dworzak; Barbara De Moerloose; Jan Starý; Owen P Smith; Riccardo Masetti; Albert Catala; Eva Bergstraesser; Marek Ussowicz; Oskana Fabri; André Baruchel; Hélène Cavé; Michel Zwaan; Franco Locatelli; Henrik Hasle; Marry M van den Heuvel-Eibrink; Christian Flotho; Ayami Yoshimi
Journal:  Haematologica       Date:  2015-01       Impact factor: 9.941

Review 9.  RAS diseases in children.

Authors:  Charlotte M Niemeyer
Journal:  Haematologica       Date:  2014-11       Impact factor: 9.941

10.  Long-term serial xenotransplantation of juvenile myelomonocytic leukemia recapitulates human disease in Rag2-/-γc-/- mice.

Authors:  Christopher Felix Krombholz; Konrad Aumann; Matthias Kollek; Daniela Bertele; Silvia Fluhr; Mirjam Kunze; Charlotte M Niemeyer; Christian Flotho; Miriam Erlacher
Journal:  Haematologica       Date:  2016-02-17       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.